Capoy, Gresila B.

HRN: 26-59-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/26/2026
02/02/2026
IV
2.25g
Q6
Decubitus Ulcer S4
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines